WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Sellas Life Sciences Group
Sellas Life Sciences Group
University of Nebraska
Dartmouth-Hitchcock Medical Center
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center